Kenichi Maruyama, GORYO Chemical – Navigation Drugs | LSI Asia '25

GORYO Chemical has developed a series of activatable fluorescent probes, collectively known as Navigation Drugs (ND), designed to enhance the precision of cancer surgeries. These probes emit minimal fluorescence until they interact with specific enzymes overexpressed in cancerous tissues, allowing for the detection of minute cancer sites that are typically challenging to identify. The technology aims to improve surgical outcomes by reducing the likelihood of residual cancer cells and minimizing the need for repeat surgeries.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach